Novo Nordisk A/S(NYSE : NVO)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||-1.52%||162.24||0.7%||$972.90m|
|MRK||Merck & Co., Inc.||-0.30%||71.47||0.7%||$794.72m|
|LLY||Eli Lilly & Co.||-0.47%||229.01||1.1%||$591.74m|
|BMY||Bristol-Myers Squibb Co.||-1.68%||60.28||1.0%||$542.97m|
|RPRX||Royalty Pharma Plc||-4.97%||36.59||0.1%||$113.18m|
|NVO||Novo Nordisk A/S||-2.26%||99.12||0.1%||$106.86m|
|APLS||Apellis Pharmaceuticals, Inc.||-4.01%||32.84||0.0%||$93.05m|
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in BagsvÃ¦rd, Denmark.